Mast Therapeutics (MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
- Wall St. lower as earnings from some big names disappoint
- Unusual 11 Mid-Day Movers 10/25: (CWEI) (NXTD) (EYES) Higher; (DPRX) (CRBP) (CALA) Lower (more...)
- General Motors (GM) Tops Q3 EPS by 28c
- Procter & Gamble (PG) Tops Q1 EPS by 5c
- DuPont (DD) Tops Q3 EPS by 14c; Boosts FY16 EPS Outlook; Says Continuing to Work with Regulators
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Mast Therapeutics (NYSE: MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ContraVir Pharma (CTRV) Gains on Heavy Volume
- Apple (AAPL) October weekly volatility increases into Q4 and outlook
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesRodman & Renshaw
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!